Navigation Links
In-country OB/GYN training programs contributed to retention of doctors in Ghana, U-M study shows
Date:9/29/2010

02, 30% of physicians trained in Ghana were practicing in the United States or Canada. In 2003, the United Kingdom approved 850 work permits for Ghanaian health and medical personnel, including physicians and nurses.

The new U-M study took place in July 2006 and consisted of a survey of 20 residents and interviews with a smaller group of nine residents at the Korle-Bu Teaching Hospital in Accra, one of U-M's partner universities in Ghana. It looked at factors that affected physician retention including having an in-country training program, social factors and the economy.

"Economic factors tend to push people out of Ghana," Anderson says, adding that social factors serve as a strong counterpoint. "Ghanaians love Ghana. People love their countries and if they have opportunity to stay, they'll stay. It's not our role as an academic institution to contribute to brain drain."

Most respondents (95%) said they would have left Ghana if postgraduate training had not been available, (80%) reported that becoming an OB/GYN specialty was important to them, (75%) indicated that the program trained them to practice in Ghana, and (85%) were certain they would stay in Ghana after completing the program.

Previous studies have shown that in-country residency programs help retain physicians. A previous study of certified specialists who had completed an academic university-based postgraduate training program in Obstetrics and Gynecology at both the Korle-Bu Teaching Hospital (Accra, Ghana) and the Komfo Anokye Teaching Hospital (Kumasi, Ghana), showed that 29 out of 30 residents stayed in the country.

According to those studies, high retention was due to the availability and presence of a viable training program in Ghana while social and economic factors also played a significant role in graduates' decisions to stay in Ghana, Anderson says.

Interest in OB/GYN among Ghanaian residents is high. Given that obtaining OB/GYN training
'/>"/>

Contact: Margarita B. Wagerson
mbauza@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Training the trainers: How to minimize stress when horses are first ridden
2. UMMC and Mayo Clinic sign agreement to increase research and training
3. Pathologists call for new training program to support personalized medicine
4. NSERC awards $3 million for UdeM and Polytechnique training programs
5. DFG establishes 12 new research training groups
6. Inspiratory muscle training and endurance sport performance
7. AAPS immunogenicity training course to be offered prior to national biotechnology conference
8. Less is more when restraining calories boosts immunity
9. Rockefeller Foundation supports expansion, training of e-health work force in developing world
10. Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing
11. Concordia University to build innovative centre for health research and training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
(Date:6/29/2015)... , June 24, 2015 ... of the "Latin America Biomedical Sensors Market - ... offering. The Latin America Biomedical Sensors market ... CAGR of 2.04% over the period 2014-2020 ... adaptable to the genetic formulation of each individual. These ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2
... farming and relieve the pressure on overexploited fish stocks. ... fish escape? Researchers at the University of Gothenburg have ... are urging caution:,-Until further notice transgenic fish should be ... at the Department of Zoology, University of Gothenburg. ...
... A research report featured on the cover of the September ... http://www.fasebj.org ) describes how Australian scientists developed a new gene ... to transport their cargo into our cells. As a result ... cell,s nucleus far more efficiently than in the past, raising ...
... from natural coal deposits in the Gulf of Alaska ... the Exxon Valdez tanker catastrophe. This clearly disproves the ... observed environmental damage. PAH pollutants were blamed for the ... Alaska. Then a dispute erupted over the origins of ...
Cached Biology News:Risks involved with transgenic fish 2Finding the ZIP-code for gene therapy: Scientists imitate viruses to deliver therapeutic genes 2Bioavailable contaminants come from the Exxon Valdez oil catastrophe 2
(Date:7/28/2015)... 28, 2015 BioStructures, LLC, a privately ... a milestone of 4,000 implantations of Signafuse® Bioactive ... in early 2014 as a bone void filler ... procedures.  This is a distinguished status among recently ... of new synthetic products have received clearance with ...
(Date:7/28/2015)... QUEBEC CITY , July 28, 2015 /PRNewswire/ ... (the "Company") today announced that it has granted to ... of funding the development and commercialization of biotechnology ... Company,s live recombinant oral allogenic tumor vaccine technology ... candidate for prostate cancer which is ready to ...
(Date:7/28/2015)... ZIONA, Israel , July 28, ... OTC:CQPTY), a regenerative medicine company utilizing its proprietary ... announced that Shomrat Shurtz has been appointed Senior ...      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ) ... years of experience in marketing, regulatory and business ...
(Date:7/27/2015)... 27, 2015  Amgen (NASDAQ: AMGN ) today ... results on Thursday, July 30, 2015, after the close ... followed by a conference call with the investment community ... Amgen will be Robert A. Bradway , chairman ... senior management team. Live audio of the ...
Breaking Biology Technology:Revolutionary Bone Graft Exceeds Expectations 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3CollPlant Names Shomrat Shurtz Senior Director of Business Development 2Amgen Announces Webcast of 2015 Second Quarter Financial Results 2
... Chromos Molecular,Systems Inc. ("Chromos" or the "Company") announced ... in the Provinces,of British Columbia, Alberta, Manitoba, Ontario ... the Company effective July 22, 2008. As a,result, ... against the,Company., The Company continues to review ...
... a video interview, new CEO,Andrew Witty comments on GSK,s second ... for the business., The new strategic ... business - Deliver more products of value - ... are available now on, http://www.cantos.com . It,s free to view. ...
... JOLLA, Calif., July 23 Duska Therapeutics,Inc. (OTC ... has,submitted for comment a synopsis of a proposed ... to the U.S. Food and Drug Administration,s (the,"FDA") ... on recent communications with the FDA, including a ...
Cached Biology Technology:Chromos Announces Full Revocation of Cease Trade Orders 2Duska Therapeutics Submits Phase 3 ATPace(TM) Protocol to FDA for Comment 2Duska Therapeutics Submits Phase 3 ATPace(TM) Protocol to FDA for Comment 3Duska Therapeutics Submits Phase 3 ATPace(TM) Protocol to FDA for Comment 4
The FailSafe™ PROBES Real-Time PCR System enables rapid, precise optimization of PCR experiments in which the product is detected using fluorescent target-specific labeled probes....
Anti-hamster Ig HRP detection kit...
...
...
Biology Products: